CA2630497A1 - Compositions a base de lipopeptide - Google Patents

Compositions a base de lipopeptide Download PDF

Info

Publication number
CA2630497A1
CA2630497A1 CA002630497A CA2630497A CA2630497A1 CA 2630497 A1 CA2630497 A1 CA 2630497A1 CA 002630497 A CA002630497 A CA 002630497A CA 2630497 A CA2630497 A CA 2630497A CA 2630497 A1 CA2630497 A1 CA 2630497A1
Authority
CA
Canada
Prior art keywords
amphomycin
cyclodextrin
derivatives
friulimicin
lipopeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002630497A
Other languages
English (en)
Inventor
Harald Labischinski
Stefan Pelzer
Horst Priefert
Andreas Vente
Sven-Eric Wohlert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merlion Pharmaceuticals GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2630497A1 publication Critical patent/CA2630497A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002630497A 2005-11-21 2006-11-20 Compositions a base de lipopeptide Abandoned CA2630497A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005056194.2 2005-11-21
DE102005056194A DE102005056194A1 (de) 2005-11-21 2005-11-21 Neue Lipopeptid Zusammensetzungen
PCT/DE2006/002064 WO2007057005A1 (fr) 2005-11-21 2006-11-20 Compositions a base de lipopeptide

Publications (1)

Publication Number Publication Date
CA2630497A1 true CA2630497A1 (fr) 2007-05-24

Family

ID=37763891

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002630497A Abandoned CA2630497A1 (fr) 2005-11-21 2006-11-20 Compositions a base de lipopeptide

Country Status (7)

Country Link
EP (1) EP1951311A1 (fr)
CN (1) CN101370524A (fr)
AU (1) AU2006314942A1 (fr)
CA (1) CA2630497A1 (fr)
DE (1) DE102005056194A1 (fr)
MX (1) MX2008006476A (fr)
WO (1) WO2007057005A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104768966B (zh) * 2012-09-24 2018-11-02 中化帝斯曼制药有限公司荷兰公司 生产环肽的方法
JP2022532045A (ja) * 2019-05-10 2022-07-13 クセリア ファーマシューティカルズ エーピーエス ダプトマイシン水性製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
CA2726789A1 (fr) * 2000-02-05 2001-11-08 Theravance, Inc. Preparations antibiotiques a base de glycopeptides contenant des cyclodextrines
WO2001097851A2 (fr) * 2000-06-21 2001-12-27 Cubist Pharmaceuticals, Inc. Compositions et methodes visant a ameliorer l'absorption orale d'agents anti-microbiens
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
US6699505B2 (en) * 2000-10-17 2004-03-02 Massachusetts Institute Of Technology Method of increasing the efficacy of antibiotics by compexing with cyclodextrins

Also Published As

Publication number Publication date
AU2006314942A1 (en) 2007-05-24
DE102005056194A1 (de) 2007-07-12
MX2008006476A (es) 2008-09-26
EP1951311A1 (fr) 2008-08-06
CN101370524A (zh) 2009-02-18
WO2007057005A1 (fr) 2007-05-24

Similar Documents

Publication Publication Date Title
CN1033738C (zh) 含有粒性的细胞集落刺激因子的稳定药剂及其生产方法
TWI282739B (en) Pharmaceutical compositions of stabilized botulinum toxin
KR101502533B1 (ko) 우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법
EP2676677B1 (fr) Préparation pharmaceutique d'anticorps anti-cd40 très concentrée
EP0091782B1 (fr) Composé d'inclusion d'antibiotiques du groupe des Lankacidines et son utilisation
CA2026149A1 (fr) Formules aqueuses stabilisees de peptides a chaines courtes
SI9200260A (en) Lipophilic oligosaccharide antibiotic salt compostition
KR100237719B1 (ko) 플루로머틸린 착체 및 이를 함유하는 약제학적 제제
US7795207B2 (en) Lipopeptide compositions
EP1947094A2 (fr) Procédé de préparation de dérivés du taxane
US20200370025A1 (en) Acute Respiratory Distress Syndrome Therapeutic Agent
EP4014969A1 (fr) Solution aqueuse
PT2047857E (pt) Agente para fins de injecção compreendendo um antibióitco, e solução para injecção compreendendo o agente
WO2017188257A1 (fr) Polyrotaxane méthylé et procédé pour sa synthèse
CN110812334A (zh) 一种注射用伏立康唑药物组合物及其制备方法
CA2949328C (fr) Polymyxines faiblement substituees et compositions les comprenant
CA2630497A1 (fr) Compositions a base de lipopeptide
EP3777862A1 (fr) Composition de méloxicam, sa préparation et son procédé de préparation et son utilisation
EA018636B1 (ru) Система доставки лекарственного средства для введения водорастворимого катионного и амфифильного фармацевтически активного вещества
EP4014965A1 (fr) Solution aqueuse
CN111465389B (zh) 多西他赛共缀物的药物组合物及制备方法
CN112999148A (zh) 复方氨基酸组合物及其制备方法
EP1994938A1 (fr) Nouvelles compositions de lipoglycodepsipeptide
CN1290506C (zh) 药物组合物
JP2002542201A (ja) シュードマイシン抗真菌組成物およびその使用方法

Legal Events

Date Code Title Description
FZDE Dead